"C\u00EDl: Zhodnotit na z\u00E1klad\u011B v\u00FDsledk\u016F registru jednoho centra proveditelnost, bezpe\u010Dnost a \u00FA\u010Dinnost implantace stent\u016F s pou\u017Eit\u00EDm za\u0159\u00EDzen\u00ED FilterWire EZTM Embolic Protection System u rizikov\u00FDch pacient\u016F s v\u00FDznamn\u00FDm aterosklerotick\u00FDm posti\u017Een\u00EDm karotick\u00FDch tepen. Metodika: V obdob\u00ED 9/2005\u201311/2008 bylo t\u00EDmto zp\u016Fsobem provedeno 226 v\u00FDkon\u016F u 185 pacient\u016F (70 +/- 9 let, 34 % symptomatick\u00FDch, 87 % s vysok\u00FDm rizikem) s pou\u017Eit\u00EDm r\u016Fzn\u00FDch stent\u016F a za\u0159\u00EDzen\u00ED FilterWire EZTM Embolic Protection System. Do studie byli za\u0159azeni pacien- ti se symptomatick\u00FDmi (50 %) i asymptomatick\u00FDmi (70 %) sten\u00F3zami. Prim\u00E1rn\u00EDm v\u00FDsledn\u00FDm ukazatelem byl 30denn\u00ED v\u00FDskyt c\u00E9vn\u00ED mozkov\u00E9 p\u0159\u00EDhody, \u00FAmrt\u00ED z neurologick\u00FDch p\u0159\u00ED\u010Din nebo v\u00FDskyt postprocedur\u00E1ln\u00EDho infarktu myokardu. V\u00FDsledky: Implantovali jsme 230 stent\u016F, sten\u00F3zy p\u0159ed v\u00FDkonem a po v\u00FDkonu byly 82 +/- 10 %, resp. 10 +/- 13 %, medi\u00E1n skiaskopick\u00E9ho \u010Dasu byl 6 minut (2,5\u201331,5 min). U jednoho pacienta se nepoda\u0159ilo v\u00FDkon prov\u00E9st a byl indikov\u00E1n k endarterektomii. Do 30 dn\u016F po dvou v\u00FDkonech n\u00E1sledovala mal\u00E1 c\u00E9vn\u00ED mozkov\u00E1 p\u0159\u00EDhoda, u jednoho velk\u00E1 c\u00E9vn\u00ED mozkov\u00E1 p\u0159\u00EDhoda a po jednom v\u00FDkonu do\u0161lo k infarktu myokardu; prim\u00E1rn\u00ED sledovan\u00FD ukazatel se vyskytl u \u010Dty\u0159 pacient\u016F (1,8 %). Dva nemocn\u00ED zem\u0159eli b\u011Bhem hospitalizace z jin\u00E9 p\u0159\u00ED\u010Diny. Z\u00E1v\u011Br: Implantace stent\u016F s pou\u017Eit\u00EDm syst\u00E9mu FilterWire EZTM Embolic Protection System je provediteln\u00E1 i bezpe\u010Dn\u00E1. Kr\u00E1tkodob\u00E9 v\u00FDsled- ky jsou z hlediska po\u017Eadavk\u016F na preventivn\u00ED l\u00E9\u010Dbu karotick\u00E9ho onemocn\u011Bn\u00ED akceptovateln\u00E9." . . "318684" . "Tomek, Ale\u0161" . "4" . "5"^^ . "Implantation of stents to significant carotid stenoses using protective system FilterWire EZ TM"@en . . "I" . "Implantace stent\u016F do v\u00FDznamn\u00FDch sten\u00F3z karotick\u00FDch tepen s pou\u017Eit\u00EDm protektivn\u00EDho syst\u00E9mu FilterWire EZ TM"@cs . . "carotid artery stenosis; stroke"@en . "Tesa\u0159, David" . . . "Veselka, Josef" . . . "Fiedler, Ji\u0159\u00ED" . "\u0160r\u00E1mek, Martin" . "11"^^ . "H\u00E1jek, Petr" . "Implantace stent\u016F do v\u00FDznamn\u00FDch sten\u00F3z karotick\u00FDch tepen s pou\u017Eit\u00EDm protektivn\u00EDho syst\u00E9mu FilterWire EZ TM" . "51" . . "11"^^ . . . . . "Objectives: To report on the early outcomes of a prospective single-center registry, which evaluated the feasibility, safety and effectiveness of carotid artery stenting using the FilterWire EZTM Embolic Protection System in high-risk patients. Methods: Between September 2005 and November 2008, 185 consecutive patients (70 +/- 9 years, 34% symptomatic, 87% at high risk) underwent 226 carotid artery stenting procedures with the FilterWire EZTM Embolic Protection System and different carotid stents. This study included both symptomatic ( 50% carotid artery stenosis) as well as asymptomatic (70% carotid artery stenosis) patients. The primary endpoint was the rate of 30-day adverse events, defined as neurological death, stroke or postprocedural myocardial infarction. Results: We implanted 230 stents, carotid artery stenoses before and after direct carotid artery stenting were 82 +/- 10% and 10 +/- 13%, respectively. The median of fluoroscopic time was 6 min (range 2.5\u201331.5 min). One patient was referred for surgical endarterectomy. There were two minor strokes, one major stroke and one myocardial infarction within 30 post-procedural days; the primary endpoint occurred in four patients (1.8%). Two patients died from non-neurological causes unrelated to carotid stenting. Conclusion: Carotid artery stenting with the FilterWire EZTM Embolic Protection System is feasible and safe. Short-term results with respect to neurological events are acceptable."@en . "Zem\u00E1nek, David" . "Implantation of stents to significant carotid stenoses using protective system FilterWire EZ TM"@en . . "Martinkovi\u010Dov\u00E1, Lucia" . "Zimolov\u00E1, Petra" . . "Implantace stent\u016F do v\u00FDznamn\u00FDch sten\u00F3z karotick\u00FDch tepen s pou\u017Eit\u00EDm protektivn\u00EDho syst\u00E9mu FilterWire EZ TM" . . "RIV/00064203:_____/09:8786!RIV13-MZ0-00064203" . "Adlov\u00E1, Radka" . "Cor et Vasa" . . "C\u00EDl: Zhodnotit na z\u00E1klad\u011B v\u00FDsledk\u016F registru jednoho centra proveditelnost, bezpe\u010Dnost a \u00FA\u010Dinnost implantace stent\u016F s pou\u017Eit\u00EDm za\u0159\u00EDzen\u00ED FilterWire EZTM Embolic Protection System u rizikov\u00FDch pacient\u016F s v\u00FDznamn\u00FDm aterosklerotick\u00FDm posti\u017Een\u00EDm karotick\u00FDch tepen. Metodika: V obdob\u00ED 9/2005\u201311/2008 bylo t\u00EDmto zp\u016Fsobem provedeno 226 v\u00FDkon\u016F u 185 pacient\u016F (70 +/- 9 let, 34 % symptomatick\u00FDch, 87 % s vysok\u00FDm rizikem) s pou\u017Eit\u00EDm r\u016Fzn\u00FDch stent\u016F a za\u0159\u00EDzen\u00ED FilterWire EZTM Embolic Protection System. Do studie byli za\u0159azeni pacien- ti se symptomatick\u00FDmi (50 %) i asymptomatick\u00FDmi (70 %) sten\u00F3zami. Prim\u00E1rn\u00EDm v\u00FDsledn\u00FDm ukazatelem byl 30denn\u00ED v\u00FDskyt c\u00E9vn\u00ED mozkov\u00E9 p\u0159\u00EDhody, \u00FAmrt\u00ED z neurologick\u00FDch p\u0159\u00ED\u010Din nebo v\u00FDskyt postprocedur\u00E1ln\u00EDho infarktu myokardu. V\u00FDsledky: Implantovali jsme 230 stent\u016F, sten\u00F3zy p\u0159ed v\u00FDkonem a po v\u00FDkonu byly 82 +/- 10 %, resp. 10 +/- 13 %, medi\u00E1n skiaskopick\u00E9ho \u010Dasu byl 6 minut (2,5\u201331,5 min). U jednoho pacienta se nepoda\u0159ilo v\u00FDkon prov\u00E9st a byl indikov\u00E1n k endarterektomii. Do 30 dn\u016F po dvou v\u00FDkonech n\u00E1sledovala mal\u00E1 c\u00E9vn\u00ED mozkov\u00E1 p\u0159\u00EDhoda, u jednoho velk\u00E1 c\u00E9vn\u00ED mozkov\u00E1 p\u0159\u00EDhoda a po jednom v\u00FDkonu do\u0161lo k infarktu myokardu; prim\u00E1rn\u00ED sledovan\u00FD ukazatel se vyskytl u \u010Dty\u0159 pacient\u016F (1,8 %). Dva nemocn\u00ED zem\u0159eli b\u011Bhem hospitalizace z jin\u00E9 p\u0159\u00ED\u010Diny. Z\u00E1v\u011Br: Implantace stent\u016F s pou\u017Eit\u00EDm syst\u00E9mu FilterWire EZTM Embolic Protection System je provediteln\u00E1 i bezpe\u010Dn\u00E1. Kr\u00E1tkodob\u00E9 v\u00FDsled- ky jsou z hlediska po\u017Eadavk\u016F na preventivn\u00ED l\u00E9\u010Dbu karotick\u00E9ho onemocn\u011Bn\u00ED akceptovateln\u00E9."@cs . . . "0010-8650" . . . "CZ - \u010Cesk\u00E1 republika" . "Implantace stent\u016F do v\u00FDznamn\u00FDch sten\u00F3z karotick\u00FDch tepen s pou\u017Eit\u00EDm protektivn\u00EDho syst\u00E9mu FilterWire EZ TM"@cs . . "Mal\u00FD, Martin" . . . "[9AE0ED1C2AD5]" . "RIV/00064203:_____/09:8786" .